Medical Device Companies Shaping the Future of Diabetes

Medical devices are rigorously assessed to meet legal requirements, ensuring they are safe and effective. These devices are essential for diagnosing illnesses, monitoring treatments, supporting people with disabilities, and managing conditions like diabetes.

In the UK, over 5.6 million people live with diabetes, and the NHS estimates more than half a million are at risk of developing type 2 diabetes within the next year. This serious condition can lead to complications such as sight loss, kidney failure, heart attacks and strokes.

Advances in medical technology are playing a crucial role in managing diabetes and improving quality of life.

Here are three companies leading the way in diabetes therapy and monitoring:

Dexcom

Established in 1999, Dexcom introduced its first continuous glucose monitoring (CGM) sensor in 2004 and has since become a global leader in diabetes care technology.

• Dexcom G6: This CGM system broke new ground as the first to integrate seamlessly with connected closed-loop systems and digital health apps. Crucially, it eliminates the need for finger-prick testing, which was previously the only way to monitor glucose levels.
• Dexcom G7: The latest innovation from Dexcom, this CGM system connects directly to an Apple Watch, delivering real-time glucose readings. This feature offers users greater convenience and freedom, removing the need to rely on a smartphone.

Medtronic

As the world’s largest medical technology company, Medtronic has been at the forefront of healthcare innovation since 1949. Their MiniMed 780G system combines advanced technology for seamless glucose monitoring and insulin delivery:

• Insulin Pump: Automatically adjusts insulin delivery based on real-time glucose data using SmartGuard technology, ensuring levels remain balanced.
• Simplera Sync Sensor: A discreet, all-in-one sensor that measures glucose every five minutes and transmits data to the pump. It is quick to insert, taking less than 10 seconds, and eliminates the need for finger pricks.
• Extended Infusion Set: Reduces the frequency of injections, requiring only one set change every seven days. This makes the process more convenient while also reducing plastic waste.

Abbott

Abbott Laboratories, founded in 1888, has a long history of driving healthcare innovation. Their FreeStyle Libre range has set the standard for sensor-based glucose monitoring:

• FreeStyle Libre 2: This system allows users to scan the sensor with their smartphone, providing instant glucose readings, an eight-hour history, and trends showing whether glucose levels are rising, falling, or steady. Optional alarms add an extra layer of safety.
• FreeStyle Libre 3: Abbott’s smallest and most discreet sensor yet, worn on the back of the upper arm. It continuously measures glucose in the body’s interstitial fluid, updating results every minute and sending the data directly to the user’s smartphone.

Recruitment in Medical Devices

At Peopleforce we provide tailored workforce solutions for the Medical device sector. As technology continues to drive advancements in healthcare, we connect leading companies with skilled professionals to support innovation and ensure high quality products.

Whether you’re looking for the right candidates to strengthen your team or seeking your next opportunity, Peopleforce is dedicated to helping you thrive in this industry.